Guggenheim Capital’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-27,644
| Closed | -$15K | – | 3099 |
|
|
2016
Q3 | $15K | Buy |
27,644
+15,393
| +126% | +$8.35K | ﹤0.01% | 2850 |
|
|
2016
Q2 | $7K | Sell |
12,251
-1,039
| -8% | -$594 | ﹤0.01% | 2862 |
|
|
2016
Q1 | $20K | Sell |
13,290
-5,470
| -29% | -$8.23K | ﹤0.01% | 2827 |
|
|
2015
Q4 | $60K | Buy |
18,760
+7,154
| +62% | +$22.9K | ﹤0.01% | 2884 |
|
|
2015
Q3 | $73K | Buy |
11,606
+760
| +7% | +$4.78K | ﹤0.01% | 2825 |
|
|
2015
Q2 | $108K | Sell |
10,846
-1,122
| -9% | -$11.2K | ﹤0.01% | 2889 |
|
|
2015
Q1 | $88K | Buy |
11,968
+1,117
| +10% | +$8.21K | ﹤0.01% | 2870 |
|
|
2014
Q4 | $58K | Buy |
+10,851
| New | +$58K | ﹤0.01% | 2898 |
|
|
2014
Q3 | – | Sell |
-18,877
| Closed | -$126K | – | 3242 |
|
|
2014
Q2 | $126K | Buy |
18,877
+4,951
| +36% | +$33K | ﹤0.01% | 2930 |
|
|
2014
Q1 | $101K | Buy |
13,926
+3,166
| +29% | +$23K | ﹤0.01% | 2974 |
|
|
2013
Q4 | $41K | Buy |
10,760
+638
| +6% | +$2.43K | ﹤0.01% | 3015 |
|
|
2013
Q3 | $34K | Buy |
+10,122
| New | +$34K | ﹤0.01% | 2917 |
|